Latest research supports Mediterranean and Asian-style eating plans to reduce risk of AMD
Read moreDriving into the future: strategies to enhance independence for drivers with macular degeneration, including licensing options and the role of modern vehicle technology
Leeloo, one of our dedicated Peer Support Facilitators, volunteers her time to helping build a space where people living with macular disease can connect and feel stronger.
The Hon. Jillian Skinner AM reflects on her personal challenge of giving up driving at night, as new research highlights mental health impacts of driving cessation.
May marks Macula Month, a national call to action for Australians to prioritise their eye health and take steps to prevent vision loss caused by macular disease.
A powerful personal journey to mark Macula Month
By The Hon. Jillian Skinner, AM, former NSW Minister for Health.This article was originally published by News Corp.
Welcome to our final Vision Voice newsletter for the year.
MDFA has received a positive response from the people participating in our new Eye Connect support service.
Macular Disease Foundation Australia (MDFA) has launched its new Research Impact Report, which showcases the groundbreaking projects our organisation has funded to help reduce the impact of macular disease.
The Federal Government has announced that from 1 July 2025, people receiving sight-saving eye (intravitreal) injections to treat macular disease will no longer receive health fund benefits for this treatment if it is performed in private hospitals and day surgeries.
Dilini is one of MDFA’s Health Promotion Officers supporting people with age-related macular degeneration through our new Eye Connect service. A qualified Vision Scientist and training Optometrist, let’s find out more about Dilini and her experiences helping people with macular disease, Australia’s leading cause of blindness.
Welcome to the Spring 2024 edition of Vision Voice.
Driving into the future: strategies to enhance independence for drivers with macular degeneration, including licensing options and the role of modern vehicle technology
Exploring exosomal therapeutics delivery strategies for macular disease
Reducing the risk of end-stage complications of neovascular age-related macular degeneration (AMD): macular atrophy and subretinal fibrosis
Towards a personalised approach to predicting and preventing progression of age-related macular degeneration
Genotype-phenotype correlations in PRPH2-associated retinal dystrophy
Nocturnal hypoxia: An unrecognised risk factor for neovascular age-related macular degeneration
Macular vascular disease: software standardisation and data harmonisation to accelerate the development of new imaging biomarkers and therapies
Next-generation gene therapy for Stargardt Disease: Enhanced AAV-mediated ABCA4 delivery to restore vision
Welcome to the latest edition of Vision Voice.
We aim to respond to your request by the next business day. If you require assistance sooner, please call our National Helpline on 1800 111 709 (Monday - Friday 9-5pm AEST).
If your query is about an eye emergency - including sudden changes to your vision or eye pain - please contact your optometrist or ophthalmologist as soon as possible.
Great!